A programmable five-position stirring hot plate offering precise temperature control and multiple stirring positions has been launched by Torrey Pines Scientific. The EchoTherm Model HS65 aims to enhance laboratory workflow efficiency in chemical, pharmaceutical, environmental and biochemical applications where reproducible sample preparation is essential.
Cambridge-based Panakeia has announced PANProfiler Colon, an artificial intelligence-driven software tool that determines micro-satellite instability (MSI) and mismatch repair deficiency (dMMR) status from H&E-stained tissue samples within minutes. The technology aims to accelerate molecular profiling for precision medicine in colorectal cancer treatment.
German CDMO ProBioGen has announced significant expansion of its biomanufacturing capabilities through commissioning of an additional 1000L GMP production line for protein therapeutics and completion of a new viral vector manufacturing unit at its Berlin facilities.
Bio-Rad Laboratories has introduced a new mixed-mode chromatography resin designed for biomolecule purification across multiple scales. The Nuvia wPrime 2A Media combines weak anion exchange with hydrophobic interaction chromatography, offering potential advantages for both research and industrial-scale therapeutic protein production
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Touchlight’s Hampton facility a Manufacturer’s Authorisation for Investigational Medicinal Products (MIA, IMP) licence, marking a significant advancement in synthetic DNA production. This certification enables the manufacture of Investigational Active Pharmaceutical Ingredients (API) and critical starting materials for Advanced Therapy Medicinal Products (ATMP).
Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific have announced a strategic partnership to optimise T cell expansion protocols, combining Terumo BCT’s Quantum Flex Cell Expansion System with FUJIFILM’s PRIME-XV T Cell Expansion Media. This collaboration addresses significant manufacturing challenges faced by cell therapy developers, particularly those in early-stage development.
Monheim-based Cube Biotech has acquired IBA Lifesciences in a strategic transaction that combines two significant players in protein research and production technologies. The acquisition, announced on 13 January 2025, creates an entity with enhanced capabilities in membrane protein production, purification, and stabilisation technologies.
Cambridge-based organ-on-chip (OOC) technology developer CN Bio has established a strategic partnership with Japanese distributor Primetech Corporation to expand access to its microphysiological systems throughout Japan. The collaboration arrives as the Japanese OOC market demonstrates significant growth potential, with projections indicating a market value of £22.1M by 2030, representing a compound annual growth rate of […]
Cambridge-based Abselion has secured £6.6 million in Series A financing to commercialise its Amperia protein analyser system, which enables rapid at-line quantification of antibodies, AAVs and other proteins from crude samples. The funding round was led by M Ventures, with participation from new and existing investors.
To highlight women’s health with a new Women’s Health Leadership Forum The Women’s Health Leadership Forum at Medlab Middle East will be centred on ‘Advancing Women’s Health Through Laboratory Diagnostics’ The new forum will underscore the importance of early detection and prevention for breast cancer, cervical cancer, PCOS, and reproductive health disorders The forum will […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
